De.mem Limited (DEM.AX) Stock

About De.mem Limited

Established in 2013 and headquartered in Melbourne, Australia, De.mem Limited specializes in the conceptualization, construction, ownership, and management of autonomous water and wastewater treatment infrastructure. Their services primarily cater to industrial, municipal, and residential clients throughout Australia, Singapore, and Germany. The company's technology portfolio is extensive, featuring advanced disinfection methods like chlorination and ultraviolet systems, alongside biological treatments such as aerobic and anaerobic processes, and diverse chemical dosing applications. A core offering involves various membrane-based water purification systems, including microfiltration, ultrafiltration, hollow fiber nanofiltration, reverse osmosis, membrane bioreactors, and forward osmosis. Complementing these are specialized processes like dissolved air flotation, media filtration, and ion exchange. Beyond core treatment solutions, De.mem provides sophisticated programmable logic controller and automation systems, as well as comprehensive sludge management services. Their expertise extends to delivering solutions for potable water, sewage treatment, industrial wastewater recycling, desalination, and process water requirements. Moreover, they offer full operational and maintenance support for treatment facilities, coupled with expert consulting, engineering, optimization, and technical advisory services. The company also engages in flexible business models such as Build-Own-Operate (BOO) and Build-Own-Operate-Transfer (BOOT). De.mem serves a broad spectrum of industries, including mining, infrastructure, electronics, chemicals, oil and gas, and food and beverage.

De.mem Limited is led by CEO Andreas Richard Kroell, employs 80 people, headquartered in Melbourne, AU, publicly traded since 2017.

over the past 52 weeks the stock has ranged between $0.06 and $0.12, and currently trades 16.7% below its 52-week high.

Official website: demembranes.com